Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bioventus Inc. - Class A Common Stock (NQ:BVS)

6.625 +0.095 (+1.45%)
Streaming Delayed Price Updated: 1:15 PM EDT, May 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bioventus Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Bioventus Reports First Quarter Financial Results
From Bioventus, Inc.
Via GlobeNewswire
Earnings Scheduled For May 6, 2025
Via Benzinga
Examining the Future: Bioventus's Earnings Outlook
Via Benzinga
Bioventus to Report First Quarter of Fiscal Year 2025 Financial Results on May 6, 2025
From Bioventus, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Gapping stocks in Tuesday's session
Let's have a look at what is happening on the US markets on Tuesday. Below you can find the gap up and gap down stocks in today's session. 
Via Chartmill
Medical Device Firm Bioventus Stock Jumps On Upbeat 2025 Outlook, Cuts Debt By $48 Million
Bioventus posted strong Q4 results, with EPS and revenue surpassing estimates. The company projects 2025 sales of $560M–$570M and adjusted EPS of $0.64–$0.68. 
Via Benzinga
Stay updated with the stocks that are on the move in today's pre-market session.
As we await the opening of the US market on Tuesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
Via Chartmill
Korn Ferry Posts Better-Than-Expected Earnings, Joins Bioventus, Endeavour Silver, Vail Resorts And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Bioventus Announces Fourth Quarter and Full Year 2024 Financial Results
From Bioventus, Inc.
Via GlobeNewswire
Earnings Scheduled For March 11, 2025
Via Benzinga
Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025
From Bioventus, Inc.
Via GlobeNewswire
Bioventus to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From Bioventus, Inc.
Via GlobeNewswire
Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners
From Bioventus, Inc.
Via GlobeNewswire
Dow Jumps 400 Points; Yum! Brands Posts Downbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
S&P 500 Gains 1%; Vimeo Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Nasdaq Gains Over 100 Points; US Trade Deficit Widens In September
Via Benzinga
Bioventus Reports Third Quarter Financial Results
From Bioventus, Inc.
Via GlobeNewswire
Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024
From Bioventus, Inc.
Via GlobeNewswire
Solventum Stock Earns 81 RS Rating
Solventum stock saw a positive improvement to its Relative Strength Rating on Tuesday, with an upgrade from 78 to 81. 
Via Investor's Business Daily
Bioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed Partners
From Bioventus, Inc.
Via GlobeNewswire
Executives Buying W. P. Carey And 2 Other Stocks
Via Benzinga
Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference
From Bioventus, Inc.
Via GlobeNewswire
BVS Stock Earnings: Bioventus Beats EPS, Beats Revenue for Q2 2024
BVS stock results show that Bioventus beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Yum China Posts Upbeat Earnings, Joins Clear Secure, TG Therapeutics, Bioventus And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Bioventus Reports Second Quarter Financial Results
From Bioventus, Inc.
Via GlobeNewswire
BIOVENTUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Bioventus Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Bioventus to Report Second Quarter of Fiscal Year 2024 Financial Results on August 6, 2024
From Bioventus, Inc.
Via GlobeNewswire
3 Stocks Under $10 With Mammoth Growth Prospects
Learn more about the growth stocks under $10 with progressive fundamentals in the healthcare and technology sectors. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.